EDGAR Filing Documents for 0001193125-15-336549

Form F-3 - Registration statement by foreign private issuers:

SEC Accession No. 0001193125-15-336549

Filing Date

2015-10-02

Accepted

2015-10-02 16:11:05

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	F-3	d42264df3.htm	F-3	405819
2	EX-1.2	d42264dex12.htm	EX-1.2	195425
3	EX-5.1	d42264dex51.htm	EX-5.1	28822
4	EX-5.2	d42264dex52.htm	EX-5.2	9677
5	EX-5.3	d42264dex53.htm	EX-5.3	29303
6	EX-23.1	d42264dex231.htm	EX-23.1	1365
7	GRAPHIC	g42264g15a09.jpg	GRAPHIC	23181
8	GRAPHIC	g42264g87o78.jpg	GRAPHIC	5908
9	GRAPHIC	g42264g90s67.jpg	GRAPHIC	50097
10	GRAPHIC	g42264image001.jpg	GRAPHIC	5908
	Complete submission text file	0001193125-15-336549.txt		788860

Mailing Address DARWINWEG 24 LEIDEN P7 2333CR

Business Address DARWINWEG 24 LEIDEN P7 2333CR 31(0)88 166 7000

ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-207245 | Film No.: 151140401
SIC: 2834 Pharmaceutical Preparations